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Our goal is to develop the functionalized superparamagnetic iron oxide nanoparticles (SPIONs) demonstrating the capacities to
be delivered in liver speciﬁcally and to be dispersed in physiological environment stably. For this purpose, SPIONs were coated
with polyvinylbenzyl- O-β-D-galactopyranosyl-D-gluconamide (PVLA) having galactose moieties to be recognized by asialogly-
coprotein receptors (ASGP-R) on hepatocytes. For use as a control, we also prepared SPIONs coordinated with 2-pyrrolidone.
The sizes, size distribution, structure, and coating of the nanoparticles were characterized by transmission electron microscopy
(TEM), electrophoretic light scattering spectrophotometer (ELS), X-ray diﬀractometer (XRD), and Fourier transform infrared
(FT-IR), respectively. Intracellular uptake of the PVLA-coated SPIONs was visualized by confocal laser scanning microscopy, and
their hepatocyte-speciﬁc delivery was also investigated through magnetic resonance (MR) images of rat liver. MRI experimental
results indicated that the PVLA-coated SPIONs possess the more speciﬁc accumulation property in liver compared with control,
which suggests their potential utility as liver-targeting MRI contrast agent.
Copyright © 2007 Mi Kyong Yoo et al. This is an open access article distributed under the Creative Commons Attribution License,
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
1. INTRODUCTION
In the last decade, many investigations with several types of
iron oxides have been carried out in the ﬁeld of nanosized
magnetic particles (mostly, magnetite (Fe3O4)o rm a gh e m i t e
(γ-Fe2O3) single domains of about 5∼20nm in diameter)
[1]. These iron oxide particles of nanometer size present su-
perparamagnetic property and are ideal for magnetic reso-
nanceimaging(MRI)contrastagentbyenhancementofpro-
ton relaxation in the tissue microenvironment [2–4].
For the MRI application, these SPIONs must have high
magnetization values, stability in physiological environment,
and size smaller than 20nm with overall narrow particle size
distribution so that the particles have uniform physical and
chemical properties [5]. However, the iron oxide magnetic
nanoparticles have several problems such as aggregation in
water, chemical instability in air, biodegradability in physi-
ological environment, and toxicity, which limit their use to
the medical diagnostic agent. Ferroﬂuids are colloidal sus-
pensions of magnetic nanoparticles, forming magnetizable
ﬂuids that remain liquid in the most intense magnetic ﬁelds
[6]. Even though the stability of the ferroﬂuid is of utmost
importanceforitsbiomedicalapplications,thenanoparticles
in colloidal suspension are likely to agglomerate and form
large cluster due to hydrophobic interactions between the
magnetic iron oxide particles with a large hydrophobic sur-
face area to volume ratio [1] .T h e s ep r o b l e m so fn a k e di r o n
oxide nanoparticles have been overcome by coating the sur-
face of magnetic particles with synthetic polymers such as
polyethylene glycol (PEG) [7], polyvinyl alchol (PVA) [8],
polyvinyl pyrrolidone (PVP) [9], and natural polymers like
dextran [10], chitosan [11], and pullulan [12]. However, the
nanoparticles coated with the above-mentioned polymers
werenonspeciﬁcallyaccumulatedintotissuesandorgans,re-
sulting in the poor availability in the imaging of speciﬁc tis-
sues and organs [13, 14]. Therefore, targeted delivery of MRI
contrast agent is a highly desirable strategy for enhancing
eﬃciency and reducing unintended side-eﬀects and toxicity2 Journal of Biomedicine and Biotechnology
[14, 15]. One strategy to realize eﬃcient and speciﬁc deliv-
ery of SPIONs is to modify the nanoparticle surface with a
ligand that is eﬃciently taken up by target cells via receptor-
mediated endocytosis [16].
In this work, our prime aim is to achieve hepatocytes-
speciﬁc delivery of SPIONs by coating with galactose-
carrying polymer for liver imaging as well as to enhance their
functions in vivo containing the stabilization of magnetic
ﬂuid suspension.
PVLA, that is, a galactose-carrying polymer, has an am-
phiphilic structural unit composed of hydrophilic oligosac-
charide side chains covalently bound to a hydrophobic
polystyrene backbone. The binding proﬁle of the carbohy-
drating ligandswithcellsurfacereceptorshasbeen wellchar-
acterized for ASGP-R on hepatic parenchyma1 cells [17–19].
The ASGP-R recognizes galactose or N-acetylgalactosamine
residues of desialylated glycoproteins and brings into the
hepatocytesthroughendocytoticprocessasaligand-receptor
complex [20, 21]. Further, the amphiphilic structure of
PVLA allows it to serve as an emulsiﬁer. Maruyama et al.
reported that the nanoparticles prepared using the PLVA as
an emulsiﬁer were hardly aggregated during storage and cen-
trifugal treatment [22]. Therefore, such capabilities of PVLA
will open the door to the design and synthesis of MRI con-
trast agent that can be accumulated speciﬁcallyon liver with-
out aggregation in physiological medium.
In this study, PVLA-coated SPIONs were prepared by
traditional coprecipitation method, followed by a thermo-
chemical treatment and postcoating with PVLA solution.
Various characterization techniques have been applied to
obtain information about the sizes, structure, and coating
of the nanoparticles. Intracellular traﬃcking of the PVLA-
coated SPIONs was visualized by confocal laser scanning mi-
croscopy and their hepatocyte-speciﬁc delivery was also in-
vestigated through MR images of rat liver.
2. MATERIALS AND METHODS
2.1. Materials
Ferric chloride hexahydrate (FeCl3·6H2O > 97%) and fer-
rous chloride tetrahydrate (FeCl2·4H2O > 99%) were pur-
chased from Sigma-Aldrich (St. Luois, Miss, USA). PVLA
(MW =5×104)waspreparedbythesamemethodpreviously
reported [23]. The chemical structure of PVLA is shown in
Figure 1. Fluorescence labeling of PVLA was performed sim-
ilartothemethod previouslydescribed[22].All other chem-
icals were of analytical reagent grade and were used without
further puriﬁcation.
2.2. Ironoxidenanoparticles
PVLA-coated SPIONs were prepared by alkaline coprecipita-
tion of ferric and ferrous chlorides in aqueous solution [24,
25]. FeCl3·6H2O (3.255g, 12.04mmol) and FeCl2·4H2O
(1.197g, 6.02mmol) were dissolved in 70mL of deoxy-
genated water, respectively. In a typical experimental proce-
dure, the solutions were mixed and precipitated by adding
7mL of NH 4OH solution (28–30%) while stirring vigor-
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Figure 1: Chemical structure of PVLA, β-galactose-carrying poly-
mer.
ously. The black precipitate which immediately formed was
washed several times with ultrapure water until the pH de-
creased from 10 to 7. After sedimenting the precipitate with
a permanent magnet, the supernatant was removed by de-
cantation. Then 20mL of 2M HNO3 was added to the black
sediment and the mixture was stirred for 5 minutes. After
adding 30mL of 0.35M Fe(NO3)3 to the mixture, it was re-
ﬂuxed for 1 hour under nitrogen gas. During this step, the
initial black slurry turned brown. The system was allowed
to cool to room temperature, the remaining liquid was dis-
carded, and 50mL of ultrapure water was added to the slurry
which immediately dispersed. The brown suspension was di-
alyzedfor2daysagainst0.01Mnitricacid,andstoredat4◦C.
In a ﬁnal step, the obtained product was mixed with solution
of PVLA to obtain SPIONs coated with PVLA. For biolog-
ical investigations, the pH was adjusted to 7 using aqueous
ammonia [8]. The content of SPIONs in the ferroﬂuid was
determined by dry weight analysis [26].
For use as a control, 2-pyrrolidone-coated SPIONs were
prepared through thermal decomposition of ferric triacety-
lacetonate (Fe(acac)3) in hot organic solvent, 2-pyrrolidone,
by following previously developed method [27]. However, 2-
pyrrolidone not only serves as a media for high-temperature
reaction, but also involves surface coordination which ren-
ders the magnetic nanoparticles water-soluble and colloidal
solution stable [27]. Before the sample was withdrawn, the
dispersed solution was sonicated for 5 minutes to obtain the
better particle dispersion.
2.3. Characterization
Fourier transform infrared (FT-IR) spectra were recorded in
thetransmissionmodeonaNicoletMagna550seriesIIspec-
trometer (Midac, Atlanta, Ga, USA). The transparent ﬁlms
forSPIONs,PVLA,andPVLA-coatedSPIONswereprepared
bycastingeachsolutiononsiliconwaferandfollowedbydry-
ing at room temperature.
The size of SPIONs was assessed using an electrophoretic
light scattering spectrophotometer (ELS 8000, Otsuka Elec-
tronics, Osaka, Japan) with 90◦ and 20◦ scattering angles at
25◦C. The volume of the samples was 4mL containing a ﬁnal
concentration of 1mg/mL in distilled water.
The average particle size and morphology of SPIONs
were observed by transmission electron microscopy (TEM)Mi Kyong Yoo et al. 3
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Figure 2: FTIRspectraofSPIONs(a),PVLA(b),andPVLA-coated
SPIONs (c).
using a JEOL Model JEM 1010 at 80kV. For sample prepa-
ration, a diluted drop of SPIONs suspension was placed on
a carbon-coated copper grid. The grid was allowed in air to
dry further for 15 minutes and was then examined with the
electron microscope.
To investigate the nanocrystallinity of SPIONs, X-ray
diﬀraction (XRD) data were collected on an X-ray diﬀrac-
tometer (Bruker-AXS GmbH D8 Advance, Karlsruhe, Ger-
many) equipped with a rotating anode, Sol-X energy disper-
sive detector, and Cu-Kα radiation source (λ = 0.1542nm).
2.4. Hepatocyteisolationandculture
Hepatocytes were prepared by noncirculation perfusion of
male ICR mouse liver with a two-step collagenase perfusion
technique of Seglen [28]. Brieﬂy, the male ICR mice (5–7
weeks of age) employed in this study were purchased from
Jungang Lab. Animal, Inc. (Seoul, Korea). The liver was per-
fusedby0.5mMofethyleneglycol-bis[β-aminoethylether]-
N,N,N  ,N  -tetraacetic acid (EGTA) in Hanks’ balanced salt
solution (HBSS) without CaCl2 and 5 × 10
−3% (wt./wt.)
collagenase in HBSS with CaCl2 (5mM) through a dispos-
able needle (25G-1) aligned along the inferior vena cava. The
collagenase-perfusedliverwasdissected,suspendedinHBSS,
and ﬁltered through cheesecloth and 100-μm nylon mem-
brane to remove connective tissue debris and cell clumps.
Hepatocytes were puriﬁed by a density-gradient centrifu-
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Figure 3: X-ray diﬀraction patterns of 2-pyrrolidone-coated SPI-
ONs (a), PVLA-coated SPIONs (b).
gation (50g force, 10 minutes) using 45% Percoll solution
(Pharmacia, Piscataway, NJ, USA) at 4◦C. Cell viability mea-
sured by trypan blue exclusion was more than 90%.
Isolated hepatocytes were suspended in a serum-free
Williams’ E (WE) medium (Gibco BRL, NY, USA) contain-
ing 50μg/mL penicillin and 50μg/mL streptomycin.
2.5. Observationofphasecontrast,ﬂuorescence,
andconfocallaserscanningmicrographs
Theisolatedhepatocyteswereplatedoncollagen-coatedglass
coverslipsin12-wellplates(IwakiGlassCo.,Tokyo,Japan)at
1×105 cellsperwell.Thehepatocyteswereincubatedat37◦C
for 2 hours. Then, the old medium was removed and WE
medium containing FITC-PVLA-coated SPIONs (1mg/mL)
was added to cells. After 15-, 30-, and 60-minute incuba-
tion, cells were rinsed twice with 0.1M PBS. The coverslips
were enclosed in 1mL of glycerol and visualized by confo-
cal laser scanning microscope (Micro Systems LSM 410, Carl
Zeiss, Germany). Gallery mode of optical sections was used
for checking internalization of complexes into cells [29, 30].
2.6. InvivoMRimage
F o ra l lr a t s ,l i v e rM Ri m a g e sw e r et a k e np r i o ra n d1h o u r
after injection of contrast agents. PVLA-coated SPIONs
and pyrrolidone-coated SPIONs were intravenously injected
through the tail vein. Rats (SD, female, 6 weeks) were anes-
thetized withtheuseofageneralinhalationanesthesia(1.5%
isoﬂurane in a 1 : 2 mixture of O2/N2) during MR exami-
nation. MR imagings were performed with a 1.5 T MR scan-
ner(GESignaExiteTwin-speed,GEHealthCare,Milwaukee,
Wiss, USA) using an animal coil (4.3cm Quadrature volume
coil, Nova Medical System, Wilmington, Del, USA). For fast
spin echo (FSE) T2-weighted MR imaging, the following pa-
rameters were adopted: repetition time (ms/echo) time mil-
liseconds of 4,800/102, ﬂip angle of 90◦, echo train length of
8, ﬁeld of view of 6cm, section thickness of 2mm, intersec-
tion gap of 0.1mm, and 256 ×160 matrix.4 Journal of Biomedicine and Biotechnology
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Figure 4: Transmission electron micrograph of 2-pyrrolidone-
coated SPIONs (a), PVLA-coated SPIONs (b).
The quantitative analysis was performed by one radiolo-
gist for MR imaging. The signal intensity (SI) was measured
in deﬁned regions of interest (ROI) in identical site of liver
before (SI pre of liver) and after (SI post of liver) contrast in-
jection.Inaddition,theSIintheROIofbackmuscleadjacent
to the liver was measured before (SI pre of BM) and after (SI
post of BM). SI of back muscle is not aﬀected by the SPIONs
injection. Relative signal enhancement of liver was calculated
by using the formula [(SI post of liver/SI post of BM–SI pre
of liver/SI pre of BM)/SI post of liver/SI post of BM] ×100.
3. RESULTS AND DISCUSSION
3.1. Preparationandcharacterizationof
PVLA-coatedSPIONs
Surface modiﬁcation of iron oxide nanoparticles with bio-
compatible polymers is potentially beneﬁcial to prepare MRI
contrast agents for in vivo applications. In particular, tar-
geted delivering, nonaggregating, and nontoxic properties
are required for the nanoparticles to achieve the accumula-
tion in liver. To produce well-dispersed iron oxide colloidal
solutions with hepatocytes targeting properties, we prepared
SPIONs coated with PVLA having galactose residues as
hepatocyte-speciﬁcligandandservingasanemulsiﬁerdueto
its amphiphilic property [22]. The parent nanoparticles were
synthesized by coprecipitation of ferrous and ferric ions in
an aqueous solution upon addition of ammonium hydrox-
ide. Common problems of the naked magnetic nanoparti-
cles are their tendency to agglomerate once formed and their
chemical instability with respect to oxidation in air [25]. The
ﬁnal iron oxide compositions are very often intermediate
between magnetite (Fe3O4) and maghemite (γ-Fe2O3), due
to the oxidation of the particles during the synthesis [31].
The problem of oxidation-sensitive magnetite could be over-
come by the deliberate introduction of a second oxidation
step [25]. Stable ferroﬂuids for liver targeting can be pre-
pared by adsorption of PVLA on the surface of magnetic
nanoparticles after the second oxidation step. Polymer can
be adsorbed by electrostatic, covalent, hydrophobic, and hy-
drogen bonding mechanism [32]. Hydrogen bonding is as-
sumed to be the predominant mechanism for the adsorption
of nonionic polymer such as PVLA on oxide surface. The hy-
drogen bonding result from the interaction between polar
functionalgroupsofPVLAandhydroxylatedandprotonated
surface sides of the oxide [25]. The importance of surface hy-
droxyl functions in hydrogen bonding has been further veri-
ﬁed by adsorbing the polymer onto pure gold sol, the surface
of which is not oxidized and, therefore, dose not carry any
hydroxyl groups; in this case, no adsorption of the polymer
is detected [33]. Accordingly, it is believed that the hydrogen
bonding may be strengthened by the second oxidation step
mentioned above.
FTIR analysis was performed to conﬁrm the coating on
SPIONssurfacewithPVLA.Figure 2showsacomparisonbe-
tween the FTIR spectra of the SPIONs (a) the pure PVLA it-
self (b), and the PVLA-coated SPIONs (c). The presence of
magnetic iron oxide nanoparticles can be seen by two strong
absorption bands at around 631 and 564cm−1. These bands
result from split of the ν1 band at 570cm−1,w h i c hc o r r e -
sponds to the Fe–O bond of bulk magnetite [34]. Further-
more, an adsorption band was observed at around 434cm−1,
which corresponds to the shifting of the ν2 band of the Fe–
O bond of bulk magnetite (at 375cm−1)t oah i g h e rw a v e
number [34]. The strong band at 1078cm−1 as shown in the
FTIR spectrum of PVLA (b) is attributed to the skeletal vi-
brations and C−O stretch of oligosaccharide [35], and the
bandat2926cm−1 andapairofbandsat1542and1423cm−1
are attributed to the stretch of –CH2 and aromatic C=Co f
polystyrene backbone, respectively [12, 36]. In addition, the
N−H bending and C=O stretching bands are overlapped at
1647cm−1 [37]. Comparing the FTIR spectrum of SPIONs
(a) and that of PVLA-coated SPIONs (c), the characteris-
tic bands resulted from the oligosaccharide and polystyrene
containingPVLAappearednear2926and1078cm−1,respec-
tively, for PVLA-coated SPIONs, indicating that PVLA was
coated at the nanoparticle surface. After the adsorption of
PVLA, the characteristic bands of Fe–O bond of bulk mag-
netite (631 and 564cm−1) shifted to the higher wave num-
bers of about 636 and 588cm−1, an indication of the oc-
currence of hydrogen bonding between hydroxyl groups of
PVLA and hydroxylated and protonated surface sides of the
oxide.
We compared the structure, size, and uniformity of
the PVLA-coated SPIONs with those of the 2-pyrrolidone-
coated SPIONs prepared for use as a control.
Figure 3 shows the XRD patterns for the 2-pyrrolidone-
coated and PVLA-coated SPIONs. Six characteristic peaks
(2θ = 30.1, 35.5, 43.1, 53.4, 57.0, and 62.6◦), marked by
their indices [(220), (311), (400), (422), (511), and (440)],
were observed for 2-pyrrolidone-coated SPION samples.
The positions and relative intensities of all diﬀraction peaks
in Figure 3(a) match well with those from the JCPDS ﬁle
(PCPDFWIN v.2.02, PDF No. 85-1436) for magnetite and
reveal that the resultant nanoparticles were pure magnetite
with spinal structure [11]. As shown in Figure 3(b), the XRD
pattern of PVLA-coated SPIONs also proved its highly crys-
talline nature and the peaks are consistent with standard
maghemite reﬂections [38, Supporting Information], being
an indication of the magnetite-maghemite transformation
due to second oxidation step. It is already known that mag-
netite is transformed to maghemite at pH 2 upon addi-
tion of ferric ions. Jolivet and Tronc have reported on theMi Kyong Yoo et al. 5
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Figure 5: Particle size distribution proﬁles of 2-pyrrolidone-coated SPIONs (a), PVLA-coated SPIONs (b).
behaviorofcolloidalmagnetiteinacidicmediuminthepres-
ence of iron nitrate and studied the phenomena that induce
the magnetite-maghemite transformation [25, 39]. Further,
XRD conﬁrmed the high degree of crystallinity of the both
types of particles.
The shape, size, and uniformity of the 2-pyrrolidone-
coated and PVLA-coated SPIONs were observed by means
of TEM. The TEM images of these both particles show el-
lipsoidal iron oxide particles with an average size less than
10nm as shown in Figure 4.A sw e l lk n o w n ,ar e p r e s e n t a t i v e
TEMimageofnakedmagneticnanoparticlesshowedthatthe
particles strongly agglomerated [6, 25]. On the other hand,
our samples that were obtained after monomer or polymer
coating reveal well-separated particles. Especially, in PVLA-
coated particles (b), the particle distribution is more homo-
geneous than the 2-pyrrolidone-coated particles (a).
Figure 5 shows number average sizes and size distribu-
tion of synthesized magnetite and PVLA-coated SPIONs
by ELS. It was clear that size distributions of both the
2-pyrrolidone-coated and PVLA-coated SPIONs were uni-
modal and particles were uniformly prepared. The aver-
age particle sizes were 20.8 ± 4.4a n d2 5 .8 ± 6.1nmfor2-
pyrrolidone-coated and PVLA-coated SPIONs, respectively.
The average diameters obtained by ELS were larger than
the sizes determined from the TEM image for correspond-
ing samples. This may presumably be because ELS gives
a mean hydrodynamic diameter of magnetic nanoparticles
surroundedbyPVLAlayerinaqueoussolutionwhereasTEM
gives the diameter of magnetic nanoparticles alone in dry
state [40].
3.2. Observationofconfocallaser
scanningmicrographs
The FITC on the nanoparticles allowed direct visualization
of the nanoparticle uptakes into cells. Figure 6 shows ﬂuo-
rescence (a) and phasecontrast (b) micrographs of hepato-
cytes cultured in medium containing SPIONs coated with
FITC-labeled PVLA according to treatment time. The ﬂuo-
rescence micrograph demonstrates a time-dependent uptake
of FITC-PVLA-coated SPIONs into hepatocytes as shown in
Figure 6(a). A signiﬁcant uptake of the nanoparticles was
clearly observed after 1 hour of culture. We performed a
quantitativeevaluationofuptakeintheinvivoalthoughonly
qualitative evaluation was performed in the in vitro, because
the speciﬁc interaction between galactose moieties of PVLA
and asialoglycoprotein receptors in the hepatocytes has been
already reported.
It was also checked whether the PVLA-coated SPIONs
existed in the cytosol or was only attached to the plasma
membrane of hepatocyte. The cell was sectioned at vari-
ous depths from cell surface by confocal laser scanning mi-
croscopy, and each ﬂuorescence distribution was observed
(see Figure 7). Fluorescence of the magnetic nanoparticles
was observed more intensively inside the cell membrane and
uniformly distributed in the cytosol. These results suggest
that the many nanoparticles were internalized in the cytosol
through a receptor-mediated endocytosis. The aﬃnity of AS-
GPR to natural and synthetic oligosaccharides having nonre-
ducing galactose residues had been reported by Lee et al.
[17].
3.3. InvivoMRimagingofliver
We examined an applicability of the PVLA-coated SPIONs
for in vivo liver imaging based on a T2–weighted FSE echo
imaging, which is a useful way to the liver accumulation of
the magnetic nanoparticles [14]. We examined three rats to
obtain the preliminary data. Liver signal intensity of all ani-
mals showed similar degree of signal drop. We described the
typicalcaseinourexperiment.However,wedidnotcalculate
the statistical analysis due to small number of animals.
At 1 hour postinjection of the PVLA-coated SPIO, sig-
nal intensity of liver was hypointense compared to SI of
back muscle FSE T2-weighted MR image (data not shown).
The relative signal enhancement on the FSE T2-weighted6 Journal of Biomedicine and Biotechnology
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Figure 6: Fluorescence (a) and phase-contrast (b) microphotographs of hepatocytes incubated with FITC-PVLA-coated SPIONs (1mg/mL)
against time at 37◦C.
MR image was observed in the liver with a T2 signal drop
of 70.9% for PVLA-coated SPIO, indication of the accu-
mulation of nanoparticle in liver. Figure 8 shows the T2-
weighted MR images of middle part of liver before and af-
ter injection of SPIONs through tail vein. After injection
of the PVLA-coated SPIONs, the SI of liver clearly dropped
on T2-weighted MR image. The relative signal enhancement
of the T2-weighted MR image was observed in the liver
with a T2 signal drop of 75.4% for PVLA-coated SPIONs
and 36% for pyrrolidone-coated SPIONs. SI of liver on T2-
weighted MR image after injection of PVLA-coated SPIONs
was darker than that after pyrrolidone-coated SPIONs (see
Figures 8(b) and 8(d)). Thus, PVLA-coated SPIONs were
more successfully targeted the liver than pyrrolidone-coated
SPIONs.PVLA-coatedSPIONscanbeusedasthehepatocyte
targeted contrast agent such as mangafodipir trisodium, for-
merly known as Mn-DPDP [41]. Additionally, we observed
accumulation in kidneys after injection of PVLA-coated SPI-
ONs (data not shown). We think that the nanoparticles will
be cleared from kidney. Renal excretion of nanoparticles is
beneﬁcial to develop nontoxic MR nanoparticles in the clin-
ical use.Mi Kyong Yoo et al. 7
Figure 7: Confocal laser micrograph of hepatocytes incubated with FITC-PVLA coated SPIONs (1mg/mL) for 1 hour (gallery mode obser-
vation).
(a) (b) (c) (d)
Figure 8: T2-weighted MR image (b) after 1-hour injection of PVLA-coated SPIONs shows marked signal drop (darkening) of liver com-
pared to T2-weighted MR image of preinjection (a). Degree of signal drop is mild between T2-weighted MR image of pre- (c) and postinjec-
tion (d) of pyrroridone-coated SPIONs.
4. CONCLUSION
We have demonstrated that PVLA can serve as the coating
material for SPIONs to achieve the stabilization and liver-
speciﬁc delivery of ferroﬂuid. The PVLA-coated SPIONs of
about 10nm diameter having a core–shell structure with
magnetic core and polymeric shell have been successfully
prepared. The FTIR experimental results proved that the
PVLA is adsorbed onto the surface of SPIONs through the
hydrogen bonding between polar functional alcohol groups
of PVLA and hydroxylated and protonated surface sides of
the oxide. Hence the resultant nanoparticles possess an ex-
cellent solubility and stability in ferroﬂuid. In vivo experi-
mental result indicated that the PVLA-coated SPIONs were
accumulated in liver appreciably. Therefore, PVLA as a coat-
ingmaterialnotonlypreventedtheaggregationbetweenSPI-
ONsinphysiologicalmediumbutalsoprovidedacapacityto
be delivered in liver speciﬁcally, which suggests the potential
utility of PVLA-coated SPIONs as a contrast agent for liver
diagnosis.
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